- Home
- / Calithera Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Calithera Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$29.2 K
2024-10-29
Revenue
$9.8 M
FY, 2021
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26.0M | 22.3M | 9.8M | ||||||
| General and administrative expense | 5.4M | 9.1M | 10.6M | 12.5M | 13.3M | 16.6M | 20.4M | 20.9M | 13.5M |
| Operating expense total | 21.7M | 32.8M | 38.3M | 55.6M | 79.5M | 92.9M | 91.4M | 42.1M | |
| EBIT | (21.7M) | (32.8M) | (38.3M) | (29.7M) | (57.3M) | (92.9M) | (91.4M) | (115.4M) | (42.1M) |
| EBIT margin, % | -114.4% | -257.4% | |||||||
| Interest income | 3.0M | 1.3M | 345.0K | 477.0K | |||||
| Interest expense | 175.0K | 330.0K | 1.9M | 2.7M | |||||
| Pre tax profit | (27.8M) | (54.6M) | (89.9M) | (90.1M) | (115.1M) | (39.6M) | |||
| Net Income | (21.7M) | (32.6M) | (38.0M) | (27.8M) | (54.6M) | (89.9M) | (90.1M) | (115.1M) | (39.6M) |
| EPS | (7.9) |